Investigating how breast cancer and its treatment affect aging in older women
Long-Term Trajectories of Accelerated Biological Aging and Functional Decline Associated with Breast Cancer and its Treatment
This study is looking at how breast cancer and its treatments might affect aging and health over time in older women, so we can better understand the unique challenges faced by breast cancer survivors compared to those who haven't had cancer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kaiser Foundation Research Institute NIH-funded |
| Lab location | 1 site (Oakland, UNITED STATES) |
| Project ID | NIH-10908645 on NIH RePORTER |
What this research studies
This research examines the long-term effects of breast cancer and its treatments on biological aging and functional decline in older women. By analyzing data from the Women's Health Initiative, the study aims to understand how cancer and its therapies may accelerate aging processes compared to women without a cancer history. The research will track changes in health and aging over time, focusing on factors like treatment type and intensity. This comprehensive approach will help identify specific health risks faced by breast cancer survivors.
Who could benefit from this research
Good fit: Ideal candidates for this research are older women, particularly those over 65, who have a history of invasive breast cancer.
Not a fit: Patients who are younger than 21 or do not have a history of breast cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved care strategies for older breast cancer survivors, enhancing their quality of life and longevity.
How similar studies have performed: Previous research has indicated that cancer treatments can lead to accelerated aging, suggesting that this study's approach is grounded in established findings.
Where this research is happening
Oakland, UNITED STATES
- Kaiser Foundation Research Institute — Oakland, United States (Active)
Researchers
- Principal investigator: Feliciano, Elizabeth Marjorie Cespedes — Kaiser Foundation Research Institute
- Study coordinator: Feliciano, Elizabeth Marjorie Cespedes
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.